US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist

14.150
+0.440+3.21%

Close Nov 27 16:00 ET

14.300
+0.150+1.06%

Pre 08:34 ET

23.47MMarket Cap-2296P/E (TTM)

Cadrenal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cadrenal Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Cadrenal Therapeutics Earnings Reports

Cadrenal Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 16:04 ET

Cadrenal Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7 16:09 ET

Cadrenal Therapeutics | 10-Q: Q1 2024 Earnings Report

May 9 06:27 ET

Cadrenal Therapeutics | 10-K: FY2023 Annual Report

Mar 11 12:58 ET

Analyst Rating

Updated: Nov 8, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall